KCHC Annual Review 2023-24 WEB Singles - Flipbook - Page 18
How did we do?
Philanthropy and innovation
We are indebted to the generous philanthropists
who have the vision to invest in new research,
equipment and services. They, in partnership with
some of the world’s leading experts, are helping to
transform treatment and care for King’s patients.
Funded entirely by charitable donations, the
MowatLabs is a state-of-the-art paediatric
research facility at King’s College Hospital. Named
in honour of the late Professor Alex Mowat, the
UK’s first Paediatric Hepatologist, the MowatLabs
provides the best possible working environment to
coordinate and advance research into childhood
liver disease.
The MowatLabs exists for one purpose
– to transform the lives of young
people with liver disease through
pioneering research excellence.”
– Professor Anil Dhawan, Director of Research and Innovation,
King’s College Hospital
“We need to know why certain things happen in
children’s liver disease,” says Professor Dhawan.
“Once we have worked out how and why…then it is a
lot easier for us to find out what we can do about it.”
Many of MowatLabs’ breakthroughs have only
been made possible through the generosity of our
supporters and we are proud to work in partnership
with donors and clinicians to go above and beyond
what the NHS is able to provide.
3D bioprinting and bioinks
3D bioprinting is a revolutionary technology that
deposits biomaterials containing cells, known as
bioinks, into precise geometries to build 3D tissue
such as skin patches for burn grafts or cartilage for
joint repair.
Thanks to the support of Pallak and Faiza Seth, we
have been able to purchase a state-of-the-art 3D
bioprinter. Researchers will use it to create a 3D
biological environment that mimics the liver, which
will revolutionise their work and help them develop
the next generation of liver microbeads.
Over the next four years, Tim Flynn has kindly
pledged to support the MowatLabs teams’ body of
work by funding two postdoctoral researchers; one
with a focus on the use of bioprinting technology in
researching paediatric liver disease and developing
treatments, and the other on cognitive development
in young children with acute liver disease.
Professor Anil Dhawan and the team
at King’s are an amazing group of
people who I’ve had the pleasure
of working with for many years.
The work they do, the impact of
the projects developed are truly
outstanding…I feel very lucky to have
been a part of this wonderful Charity!”
– Tim Flynn
18
S U P P O R T K I N G S .O R G .U K
